These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 27122056

  • 1. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.
    Tang ST, Su H, Zhang Q, Tang HQ, Wang CJ, Zhou Q, Wei W, Zhu HQ, Wang Y.
    Int J Mol Med; 2016 Jun; 37(6):1558-66. PubMed ID: 27122056
    [Abstract] [Full Text] [Related]

  • 2. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST, Zhang Q, Tang HQ, Wang CJ, Su H, Zhou Q, Wei W, Zhu HQ, Wang Y.
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [Abstract] [Full Text] [Related]

  • 3. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y.
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [Abstract] [Full Text] [Related]

  • 4. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
    Eitah HE, Maklad YA, Abdelkader NF, Gamal El Din AA, Badawi MA, Kenawy SA.
    Toxicol Appl Pharmacol; 2019 Feb 15; 365():30-40. PubMed ID: 30576699
    [Abstract] [Full Text] [Related]

  • 5. Sitagliptin Ameliorates Creb5/lncRNA ENSMUST00000213271-Mediated Vascular Endothelial Dysfunction in Obese Mice.
    Zong Y, Wang X, Zhang Y, Tan N, Zhang Y, Li L, Liu L.
    Cardiovasc Drugs Ther; 2024 Aug 15; 38(4):679-691. PubMed ID: 36738369
    [Abstract] [Full Text] [Related]

  • 6. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
    Ren X, Liu G, Wang Y, Zhang W, Xue F, Li R, Yu W.
    Pharmacology; 2017 Aug 15; 100(1-2):1-13. PubMed ID: 28329747
    [Abstract] [Full Text] [Related]

  • 7. Sitagliptin inhibits EndMT in vitro and improves cardiac function of diabetic rats through the SDF-1α/PKA pathway.
    Wu Y, Xu M, Bao H, Zhang JH.
    Eur Rev Med Pharmacol Sci; 2019 Jan 15; 23(2):841-848. PubMed ID: 30720193
    [Abstract] [Full Text] [Related]

  • 8. Effects of sitagliptin on ß-adrenoceptor mediated relaxation in streptozotocin-diabetic rat aorta.
    Müderrisoğlu AE, Erdoğan BR, Yeşilyurt ZE, Uyar Boztaş C, Karaçömerlioğlu İ, Altan VM, Arıoğlu İnan E.
    Turk J Med Sci; 2021 Apr 30; 51(2):864-872. PubMed ID: 33185366
    [Abstract] [Full Text] [Related]

  • 9. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
    Al-Damry NT, Attia HA, Al-Rasheed NM, Al-Rasheed NM, Mohamad RA, Al-Amin MA, Dizmiri N, Atteya M.
    Biomed Pharmacother; 2018 Nov 30; 107():347-358. PubMed ID: 30099338
    [Abstract] [Full Text] [Related]

  • 10. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
    Liu YS, Huang ZW, Wang L, Liu XX, Wang YM, Zhang Y, Zhang M.
    J Pharmacol Sci; 2015 Mar 30; 127(3):260-74. PubMed ID: 25837922
    [Abstract] [Full Text] [Related]

  • 11. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
    Sangle GV, Lauffer LM, Grieco A, Trivedi S, Iakoubov R, Brubaker PL.
    Endocrinology; 2012 Feb 30; 153(2):564-73. PubMed ID: 22186413
    [Abstract] [Full Text] [Related]

  • 12. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
    Suzuki K, Uchida K, Nakanishi N, Hattori Y.
    Am J Hypertens; 2008 Apr 30; 21(4):451-7. PubMed ID: 18369362
    [Abstract] [Full Text] [Related]

  • 13. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
    Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Hayakawa M, Shibasaki M.
    Pharmacol Rep; 2009 Apr 30; 61(5):899-908. PubMed ID: 19904014
    [Abstract] [Full Text] [Related]

  • 14. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R, Shikata K, Takatsuka T, Oda K, Miyamoto S, Kajitani N, Hirota D, Ono T, Usui HK, Makino H.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):828-33. PubMed ID: 24342619
    [Abstract] [Full Text] [Related]

  • 15. Melatonin Attenuates Aortic Endothelial Permeability and Arteriosclerosis in Streptozotocin-Induced Diabetic Rats: Possible Role of MLCK- and MLCP-Dependent MLC Phosphorylation.
    Tang ST, Su H, Zhang Q, Tang HQ, Wang CJ, Zhou Q, Wei W, Zhu HQ, Wang Y.
    J Cardiovasc Pharmacol Ther; 2016 Jan 17; 21(1):82-92. PubMed ID: 25944844
    [Abstract] [Full Text] [Related]

  • 16. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
    Hu X, Liu S, Liu X, Zhang J, Liang Y, Li Y.
    Endocrine; 2017 Mar 17; 55(3):754-763. PubMed ID: 27612849
    [Abstract] [Full Text] [Related]

  • 17. Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy.
    Wang H, Zhou Y, Guo Z, Dong Y, Xu J, Huang H, Liu H, Wang W.
    J Cardiovasc Pharmacol Ther; 2018 Jan 17; 23(1):66-78. PubMed ID: 28618859
    [Abstract] [Full Text] [Related]

  • 18. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
    Guida C, McCulloch LJ, Godazgar M, Stephen SD, Baker C, Basco D, Dong J, Chen D, Clark A, Ramracheya RD.
    Diabetes Obes Metab; 2018 Mar 17; 20(3):571-581. PubMed ID: 28892258
    [Abstract] [Full Text] [Related]

  • 19. Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in streptozotocin-induced rats with type 2 diabetes.
    Liu C, Sun J, Xue F, Yi Y, Han A.
    J Cardiovasc Pharmacol; 2015 Jan 17; 65(1):22-7. PubMed ID: 25162436
    [Abstract] [Full Text] [Related]

  • 20. Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.
    Vittone F, Liberman A, Vasic D, Ostertag R, Esser M, Walcher D, Ludwig A, Marx N, Burgmaier M.
    Diabetologia; 2012 Aug 17; 55(8):2267-75. PubMed ID: 22648661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.